Australia markets closed

TransCode Therapeutics, Inc. (RNAZ)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8200+0.1130 (+15.98%)
At close: 04:00PM EDT
0.7853 -0.03 (-4.23%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
8,831
12,264
10,232
2,754
284.459
Selling general and administrative
7,293
7,155
8,401
3,397
442.145
Total operating expenses
15,238
18,495
17,553
5,873
726.604
Operating income or loss
-15,238
-18,495
-17,553
-5,873
-726.604
Interest expense
0
55.899
31.986
95.07
394.573
Total other income/expenses net
-
-
-
-876.191
-1,223
Income before tax
-15,230
-18,546
-17,565
-6,843
-2,344
Income tax expense
-
-
-
-
0
Income from continuing operations
-15,230
-18,546
-17,565
-6,843
-2,344
Net income
-15,230
-18,546
-17,565
-6,843
-2,344
Net income available to common shareholders
-15,230
-18,546
-17,565
-6,843
-2,344
Basic EPS
-652.00
-
-1.08k
-648.00
-293.76
Diluted EPS
-652.00
-
-1.08k
-648.00
-293.76
Basic average shares
36.097
-
16.222
10.532
7.979
Diluted average shares
36.097
-
16.222
10.532
7.979